U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H23NO2
Molecular Weight 261.3593
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PIPEROCAINE

SMILES

CC1CCCCN1CCCOC(=O)C2=CC=CC=C2

InChI

InChIKey=YQKAVWCGQQXBGW-UHFFFAOYSA-N
InChI=1S/C16H23NO2/c1-14-8-5-6-11-17(14)12-7-13-19-16(18)15-9-3-2-4-10-15/h2-4,9-10,14H,5-8,11-13H2,1H3

HIDE SMILES / InChI
Molecular Formula C16H23NO2
Molecular Weight 261.3593
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: Description was created using several sources including: http://www.annualreviews.org/doi/abs/10.1146/annurev.pa.09.040169.002443?journalCode=pharmtox.1; http://www.ncbi.nlm.nih.gov/pubmed/15402120; http://www.ncbi.nlm.nih.gov/pubmed/18149171; http://www.ncbi.nlm.nih.gov/pubmed/7635175; http://purl.bioontology.org/ontology/NDDF/003425; http://www.accessdata.fda.gov/scripts/animaldrugsatfda/details.cfm?dn=040-123 http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/pharmacycompounding/ucm467373.pdf; https://books.google.com/books?id=79BGAQAAMAAJ&pg=PA263&lpg=PA263&dq=METYCAINE+was+manufactured&source=bl&ots=-PQVR0IZgE&sig=9DfpIP-V1qufWzn5gmpEzdVfYVY&hl=en&sa=X&ved=0ahUKEwjr-qjk2rHLAhUJ8CYKHTG0DdkQ6AEILzAE#v=onepage&q=METYCAINE%20was%20manufactured&f=false

Piperocaine (Metycaine) is a local anesthetic drug. It is an ester and primarily is a sodium channel blocker. Piperocaine can partially inhibit dopamine. It is known as a alpha-1-proteinase inhibitor. Used in the form of its hydrochloride as a local or spinal anesthetic and in dental anesthesia. Can cause toxic reactions. Piperocaine Hydrochloride is in the list of Bulk Drug Substances Nominated for Use in Compounding Under Section 503A, FDA Act. Piperocaine hydrochloride is a small, white odorless crystals or a white crystalline powder, stable in air, freely soluble in water, alcohol and chloroform.

Approval Year

1933
6
Targets

Targets

Primary TargetPharmacologyConditionPotency
Blocker
555
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8583
Metycaine Hydrochloride

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Other AEs: Tremor, Tremor...
Other AEs:
Tremor (slight, 28.1%)
Tremor (moderate, 3.5%)
Sweating (slight, 17.5%)
Sweating (moderate, 1.8%)
Nervousness (slight, 29.8%)
Nervousness (moderate, 5.3%)
Nervousness (extreme, 8.8%)
Faintness (5.3%)
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
AEs

AEs

AESignificanceDosePopulation
Faintness 5.3%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Nervousness extreme, 8.8%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Sweating moderate, 1.8%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Tremor moderate, 3.5%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Nervousness moderate, 5.3%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Sweating slight, 17.5%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Tremor slight, 28.1%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Nervousness slight, 29.8%
60 mg single, dental
Recommended
Dose: 60 mg
Route: dental
Route: single
Dose: 60 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
unhealthy, 10-90
Health Status: unhealthy
Age Group: 10-90
Sex: M+F
Sources:
https://pubmed.ncbi.nlm.nih.gov/15402120/
Sourcing

Sourcing

Vendor/AggregatorIDURL
ABI Chem
AC1L1VXK
Alfa Chemistry
ACM533288
BOC Sciences
136-82-3
Chemieliva Pharmaceutical Co., Ltd
PBCM1168098
ChemMol
99070272
http://www.chemmol.com/chemmol/99070272.html
Compound Cloud
10781
Compound Cloud
10782
eMolecules
10170459
eMolecules
110057371
eMolecules
300113982
mcule
MCULE-4599192331
https://mcule.com/MCULE-4599192331/
MuseChem
M071487
MuseChem
R070736
NovoSeek
10782
Parchem
58000
https://www.parchem.com/chemical-supplier-distributor/Piperocaine-058000.aspx
Sigma Aldrich
S403253
Sigma Aldrich
S403253|ALDRICH
THE BioTek
bt-372036
https://www.thebiotek.com/product/others/bt-372036
TimTec
ST50443593
ZINC
ZINC000002034887
http://zinc15.docking.org/substances/ZINC000002034887
ZINC
ZINC000002034888
http://zinc15.docking.org/substances/ZINC000002034888
PubMed

PubMed

TitleDatePubMed
Mexoryl SX: a broad absorption UVA filter protects human skin from the effects of repeated suberythemal doses of UVA.
1998-06-15
Patents

Patents

US2016030408
7
US2016030476
5
US2016038462
3
US2016045413
5
US2016051516
2
US2016058752
2
US2016074515
2
US2016082038
2
US2016082150
5

Sample Use Guides

In Vivo Use Guide
For continuous caudal analgesia in obstetrics initial dose of 30 ml of 1 and 1.5 % metycaine produced analgesia as high as the line midway between the pubis and the umbilicus and relieved the pains of labor.
Route of Administration: Other
In Vitro Use Guide
At a maximum concentration of 100 uM, the ester containing local anesthetics procaine, tetracaine, piperocaine and the amide containing local anesthetic dibucaine and bupivacaine partially inhibited dopamine uptake by 47-70%
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:53:07 GMT 2025
Edited
by admin
on Mon Mar 31 17:53:07 GMT 2025
Record UNII
F66XUI6GZL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NEOTHESIN
Preferred Name English
PIPEROCAINE
INN   MI   WHO-DD  
INN  
Official Name English
.GAMMA.-(2-METHYLPIPERIDYL)PROPYL BENZOATE
Systematic Name English
1-PIPERIDINEPROPANOL, 2-METHYL-, 1-BENZOATE
Common Name English
PIPEROCAINE [MI]
Common Name English
(±)-2-METHYL-1-PIPERIDINEPROPANOL BENZOATE
Systematic Name English
Piperocaine [WHO-DD]
Common Name English
ISOCAINE BASE
Common Name English
piperocaine [INN]
Common Name English
1-PIPERIDINEPROPANOL, 2-METHYL-, BENZOATE (ESTER), (±)-
Common Name English
3-(2-METHYL-1-PIPERIDYL)PROPYL BENZOATE
Systematic Name English
(±)-3-BENZOXY-1-(2-METHYLPIPERIDINO)PROPANE
Systematic Name English
(2-METHYLPIPERIDINO)PROPYL BENZOATE
Systematic Name English
2-METHYL-1-PIPERIDINEPROPANOL BENZOATE
Systematic Name English
1-PIPERIDINEPROPANOL, 2-METHYL-, BENZOATE (ESTER)
Common Name English
METYCAINE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
Code System Code Type Description
RXCUI
33752
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY RxNorm
ECHA (EC/EINECS)
205-262-1
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
EPA CompTox
DTXSID8048315
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
FDA UNII
F66XUI6GZL
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
NCI_THESAURUS
C90654
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
EVMPD
SUB09871MIG
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
INN
4176
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
PUBCHEM
10782
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
MERCK INDEX
m8857
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
PIPEROCAINE
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
ChEMBL
CHEMBL127865
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
SMS_ID
100000081966
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
MESH
C023039
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
CAS
136-82-3
Created by admin on Mon Mar 31 17:53:07 GMT 2025 , Edited by admin on Mon Mar 31 17:53:07 GMT 2025
PRIMARY
Related Record Type Details
Structure of PIPEROCAINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of PIPEROCAINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966